The non-invasive brain trauma monitoring devices market size has grown rapidly in recent years. It will grow from $8.68 billion in 2024 to $9.65 billion in 2025 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to personalized medicine approach, focus on long-term monitoring, widespread adoption of wearables, signal sensitivity improvement, multimodal monitoring integration.
The non-invasive brain trauma monitoring devices market size is expected to see rapid growth in the next few years. It will grow to $15.15 billion in 2029 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to rise in awareness and diagnosis, collaborative research efforts, demand for long-term monitoring solutions, signal processing innovations, remote connectivity advancements. Major trends in the forecast period include miniaturization and wearable devices, advancements in sensor technology, focus on real-time monitoring, remote patient monitoring, non-invasive imaging techniques.
The increasing prevalence of neurological disorders and diseases is anticipated to boost the demand for non-invasive brain trauma monitoring devices. Neurological disorders are a significant category of non-communicable diseases (NCDs) that affect individuals' thoughts, emotions, behaviors, and injuries, including brain, spinal cord, and nerve injuries. Non-invasive brain trauma monitoring devices enable continuous patient monitoring, allowing physicians to assess critical levels and determine appropriate actions to mitigate severe trauma conditions. For example, in January 2024, the American Cancer Society, a U.S.-based nonprofit cancer advocacy organization, projected that new cases of brain cancer would reach 25,400 in 2024, up from 24,810 in 2023. Therefore, the growing incidence of neurological disorders and diseases will drive the market for non-invasive brain trauma monitoring devices.
The ascendancy of personalized medicine has significantly fueled the growth trajectory of non-invasive brain trauma monitoring devices. Personalized medicine, leveraging an individual's genetic profile for disease prevention, diagnosis, and treatment decisions, has spurred the demand for tailored monitoring approaches. This tailored strategy enhances precision and efficacy in monitoring, aligning with specific patient needs and responses. As of 2022, the Personalized Medicine Coalition projected that personalized medicines would constitute 34% of new drug approvals by the US Food and Drug Administration, underscoring the pivotal role of personalized medicine in propelling the market for these monitoring devices.
Technological advancement is a significant trend gaining traction in the non-invasive brain trauma monitoring device market. Leading companies in this sector are developing innovative technologies to bolster their market presence. For example, in May 2024, Canon Medical Systems, a Japan-based medical imaging and healthcare technology firm, launched the first installation of the Aquilion Serve SP CT scanner in the U.S., integrated with INSTINX, an AI-driven workflow automation system. This scanner aims to enhance imaging capabilities and improve patient care. Moreover, the INSTINX system serves as an AI-powered workflow automation tool that streamlines imaging processes, thereby optimizing efficiency and accuracy in clinical environments.
Major players in the non-invasive brain trauma monitoring devices sector are pioneering advanced technologies such as AI-enabled optical fiber sensor devices. These cutting-edge devices employ flexible silica-based optical fibers with four sensing films to simultaneously measure crucial biomarkers in cerebrospinal fluid. For instance, in August 2022, Imperial College London unveiled an AI-enabled, optical fiber sensor device specifically designed to measure multiple biomarkers of traumatic brain injury (TBI). Integrated with machine learning algorithms, this device predicts biomarker concentrations based on real-time data, potentially revolutionizing neurocritical care by significantly improving TBI monitoring and patient outcomes.
In November 2022, SonderMind, a digital behavioral health company situated in the United States, completed the acquisition of Total Brain for an undisclosed sum. This strategic move by SonderMind aims to provide their therapists with enhanced capabilities to track treatment outcomes, extend population health reporting services to enterprise clients, and deliver comprehensive solutions to insurers and healthcare organizations. Total Brain, based in the U.S., specializes in brain monitoring technologies.
Major companies operating in the non-invasive brain trauma monitoring devices market are Sophysa Ltd., Spiegelberg GmbH & Co. KG, Natus Medical Inc., Nihon Kohden Corporation, Philips Healthcare, Advanced Brain Monitoring, CAS Medical Systems Inc., Siemens AG, Compumedics Ltd., Medtronic Plc., Integra LifeSciences, Cadwell Industries Inc., Codman & Shurtleff Inc., Covidien PLC., Hitachi Medical Corporation, Koninklijke Philips N.V., NeuroLogica Corp., NeuroWave Systems Inc., Noraxon U.S.A, Sense Neuro Diagnostics, GE Healthcare, BrainScope Company Inc., Cerebrotech Medical Systems Inc., Neural Analytics Inc., Oculogica Inc., Ornim Medical Ltd.
North America was the largest region in the non-invasive brain trauma monitoring devices market share in 2024. The regions covered in the non-invasive brain trauma monitoring devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the non-invasive brain trauma monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Non-invasive brain trauma monitoring devices are instruments designed to monitor brain activity, neural signals, and pressure levels around the brain without the need for invasive procedures. These devices serve to analyze blood flow rates in the brain's arteries and veins, particularly crucial in cases of brain trauma, epilepsy, and brain-related injuries.
The realm of non-invasive brain trauma monitoring devices, various types exist, including the non-invasive intracranial pressure monitor and the non-invasive cerebral edema dynamic monitor, among others. The non-invasive intracranial pressure monitor plays a critical role in managing diverse neurological conditions. This device is part of an invasive system, involving a ventricular catheter linked to an external strain gauge, although it presents several complexities. These devices find applications across cardiology, urology, nephrology, oncology, gastroenterology, and other specialized fields, utilized within hospitals, neurological centers, and by various end-users.
The non-invasive brain trauma monitoring devices market research report is one of a series of new reports that provides non-invasive brain trauma monitoring devices market statistics, including non-invasive brain trauma monitoring devices industry global market size, regional shares, competitors with a non-invasive brain trauma monitoring devices market share, detailed non-invasive brain trauma monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the non-invasive brain trauma monitoring devices industry. This non-invasive brain trauma monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The non-invasive brain trauma monitoring devices market consists of sales of monitoring devices, consumables, and accessories. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The non-invasive brain trauma monitoring devices market size is expected to see rapid growth in the next few years. It will grow to $15.15 billion in 2029 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to rise in awareness and diagnosis, collaborative research efforts, demand for long-term monitoring solutions, signal processing innovations, remote connectivity advancements. Major trends in the forecast period include miniaturization and wearable devices, advancements in sensor technology, focus on real-time monitoring, remote patient monitoring, non-invasive imaging techniques.
The increasing prevalence of neurological disorders and diseases is anticipated to boost the demand for non-invasive brain trauma monitoring devices. Neurological disorders are a significant category of non-communicable diseases (NCDs) that affect individuals' thoughts, emotions, behaviors, and injuries, including brain, spinal cord, and nerve injuries. Non-invasive brain trauma monitoring devices enable continuous patient monitoring, allowing physicians to assess critical levels and determine appropriate actions to mitigate severe trauma conditions. For example, in January 2024, the American Cancer Society, a U.S.-based nonprofit cancer advocacy organization, projected that new cases of brain cancer would reach 25,400 in 2024, up from 24,810 in 2023. Therefore, the growing incidence of neurological disorders and diseases will drive the market for non-invasive brain trauma monitoring devices.
The ascendancy of personalized medicine has significantly fueled the growth trajectory of non-invasive brain trauma monitoring devices. Personalized medicine, leveraging an individual's genetic profile for disease prevention, diagnosis, and treatment decisions, has spurred the demand for tailored monitoring approaches. This tailored strategy enhances precision and efficacy in monitoring, aligning with specific patient needs and responses. As of 2022, the Personalized Medicine Coalition projected that personalized medicines would constitute 34% of new drug approvals by the US Food and Drug Administration, underscoring the pivotal role of personalized medicine in propelling the market for these monitoring devices.
Technological advancement is a significant trend gaining traction in the non-invasive brain trauma monitoring device market. Leading companies in this sector are developing innovative technologies to bolster their market presence. For example, in May 2024, Canon Medical Systems, a Japan-based medical imaging and healthcare technology firm, launched the first installation of the Aquilion Serve SP CT scanner in the U.S., integrated with INSTINX, an AI-driven workflow automation system. This scanner aims to enhance imaging capabilities and improve patient care. Moreover, the INSTINX system serves as an AI-powered workflow automation tool that streamlines imaging processes, thereby optimizing efficiency and accuracy in clinical environments.
Major players in the non-invasive brain trauma monitoring devices sector are pioneering advanced technologies such as AI-enabled optical fiber sensor devices. These cutting-edge devices employ flexible silica-based optical fibers with four sensing films to simultaneously measure crucial biomarkers in cerebrospinal fluid. For instance, in August 2022, Imperial College London unveiled an AI-enabled, optical fiber sensor device specifically designed to measure multiple biomarkers of traumatic brain injury (TBI). Integrated with machine learning algorithms, this device predicts biomarker concentrations based on real-time data, potentially revolutionizing neurocritical care by significantly improving TBI monitoring and patient outcomes.
In November 2022, SonderMind, a digital behavioral health company situated in the United States, completed the acquisition of Total Brain for an undisclosed sum. This strategic move by SonderMind aims to provide their therapists with enhanced capabilities to track treatment outcomes, extend population health reporting services to enterprise clients, and deliver comprehensive solutions to insurers and healthcare organizations. Total Brain, based in the U.S., specializes in brain monitoring technologies.
Major companies operating in the non-invasive brain trauma monitoring devices market are Sophysa Ltd., Spiegelberg GmbH & Co. KG, Natus Medical Inc., Nihon Kohden Corporation, Philips Healthcare, Advanced Brain Monitoring, CAS Medical Systems Inc., Siemens AG, Compumedics Ltd., Medtronic Plc., Integra LifeSciences, Cadwell Industries Inc., Codman & Shurtleff Inc., Covidien PLC., Hitachi Medical Corporation, Koninklijke Philips N.V., NeuroLogica Corp., NeuroWave Systems Inc., Noraxon U.S.A, Sense Neuro Diagnostics, GE Healthcare, BrainScope Company Inc., Cerebrotech Medical Systems Inc., Neural Analytics Inc., Oculogica Inc., Ornim Medical Ltd.
North America was the largest region in the non-invasive brain trauma monitoring devices market share in 2024. The regions covered in the non-invasive brain trauma monitoring devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the non-invasive brain trauma monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Non-invasive brain trauma monitoring devices are instruments designed to monitor brain activity, neural signals, and pressure levels around the brain without the need for invasive procedures. These devices serve to analyze blood flow rates in the brain's arteries and veins, particularly crucial in cases of brain trauma, epilepsy, and brain-related injuries.
The realm of non-invasive brain trauma monitoring devices, various types exist, including the non-invasive intracranial pressure monitor and the non-invasive cerebral edema dynamic monitor, among others. The non-invasive intracranial pressure monitor plays a critical role in managing diverse neurological conditions. This device is part of an invasive system, involving a ventricular catheter linked to an external strain gauge, although it presents several complexities. These devices find applications across cardiology, urology, nephrology, oncology, gastroenterology, and other specialized fields, utilized within hospitals, neurological centers, and by various end-users.
The non-invasive brain trauma monitoring devices market research report is one of a series of new reports that provides non-invasive brain trauma monitoring devices market statistics, including non-invasive brain trauma monitoring devices industry global market size, regional shares, competitors with a non-invasive brain trauma monitoring devices market share, detailed non-invasive brain trauma monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the non-invasive brain trauma monitoring devices industry. This non-invasive brain trauma monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The non-invasive brain trauma monitoring devices market consists of sales of monitoring devices, consumables, and accessories. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Non-Invasive Brain Trauma Monitoring Devices Market Characteristics3. Non-Invasive Brain Trauma Monitoring Devices Market Trends and Strategies4. Non-Invasive Brain Trauma Monitoring Devices Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market32. Global Non-Invasive Brain Trauma Monitoring Devices Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Non-Invasive Brain Trauma Monitoring Devices Market34. Recent Developments in the Non-Invasive Brain Trauma Monitoring Devices Market
5. Global Non-Invasive Brain Trauma Monitoring Devices Growth Analysis and Strategic Analysis Framework
6. Non-Invasive Brain Trauma Monitoring Devices Market Segmentation
7. Non-Invasive Brain Trauma Monitoring Devices Market Regional and Country Analysis
8. Asia-Pacific Non-Invasive Brain Trauma Monitoring Devices Market
9. China Non-Invasive Brain Trauma Monitoring Devices Market
10. India Non-Invasive Brain Trauma Monitoring Devices Market
11. Japan Non-Invasive Brain Trauma Monitoring Devices Market
12. Australia Non-Invasive Brain Trauma Monitoring Devices Market
13. Indonesia Non-Invasive Brain Trauma Monitoring Devices Market
14. South Korea Non-Invasive Brain Trauma Monitoring Devices Market
15. Western Europe Non-Invasive Brain Trauma Monitoring Devices Market
16. UK Non-Invasive Brain Trauma Monitoring Devices Market
17. Germany Non-Invasive Brain Trauma Monitoring Devices Market
18. France Non-Invasive Brain Trauma Monitoring Devices Market
19. Italy Non-Invasive Brain Trauma Monitoring Devices Market
20. Spain Non-Invasive Brain Trauma Monitoring Devices Market
21. Eastern Europe Non-Invasive Brain Trauma Monitoring Devices Market
22. Russia Non-Invasive Brain Trauma Monitoring Devices Market
23. North America Non-Invasive Brain Trauma Monitoring Devices Market
24. USA Non-Invasive Brain Trauma Monitoring Devices Market
25. Canada Non-Invasive Brain Trauma Monitoring Devices Market
26. South America Non-Invasive Brain Trauma Monitoring Devices Market
27. Brazil Non-Invasive Brain Trauma Monitoring Devices Market
28. Middle East Non-Invasive Brain Trauma Monitoring Devices Market
29. Africa Non-Invasive Brain Trauma Monitoring Devices Market
30. Non-Invasive Brain Trauma Monitoring Devices Market Competitive Landscape and Company Profiles
31. Non-Invasive Brain Trauma Monitoring Devices Market Other Major and Innovative Companies
35. Non-Invasive Brain Trauma Monitoring Devices Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Non-Invasive Brain Trauma Monitoring Devices Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on non-invasive brain trauma monitoring devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for non-invasive brain trauma monitoring devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The non-invasive brain trauma monitoring devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) by Type: Non-invasive Intracranial Pressure Monitor; Non-invasive Cerebral Edema Dynamic Monitor; Other Types2) by Application: Cardiology; Urology and Nephrology; Oncology; Gastroenterology; Other Applications
3) by End-User: Hospitals; Neurological Centers; Other End Users
Subsegments:
1) by Non-invasive Intracranial Pressure Monitor: Transcranial Doppler (TCD) Devices; Near-Infrared Spectroscopy (NIRS) Devices2) by Non-invasive Cerebral Edema Dynamic Monitor: Electrical Impedance Tomography (EIT); Magnetic Resonance Imaging (MRI)-Based Monitors
3) by Other Types: Ultrasound-Based Monitors; Bioelectrical Signal Monitors
Key Companies Mentioned: Sophysa Ltd.; Spiegelberg GmbH & Co. KG; Natus Medical Inc.; Nihon Kohden Corporation; Philips Healthcare
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
Some of the major companies featured in this Non-Invasive Brain Trauma Monitoring Devices market report include:- Sophysa Ltd.
- Spiegelberg GmbH & Co. KG
- Natus Medical Inc.
- Nihon Kohden Corporation
- Philips Healthcare
- Advanced Brain Monitoring
- CAS Medical Systems Inc.
- Siemens AG
- Compumedics Ltd.
- Medtronic Plc.
- Integra LifeSciences
- Cadwell Industries Inc.
- Codman & Shurtleff Inc.
- Covidien PLC.
- Hitachi Medical Corporation
- Koninklijke Philips N.V.
- NeuroLogica Corp.
- NeuroWave Systems Inc.
- Noraxon U.S.A
- Sense Neuro Diagnostics
- GE Healthcare
- BrainScope Company Inc.
- Cerebrotech Medical Systems Inc.
- Neural Analytics Inc.
- Oculogica Inc.
- Ornim Medical Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | February 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 9.65 Billion |
| Forecasted Market Value ( USD | $ 15.15 Billion |
| Compound Annual Growth Rate | 11.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 26 |
